Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Akkaraju Srinivas
Relationship:  
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   19    
Direct Shares   3,961,226    

Indirect Shares

   37,470,445      
Direct Value   $19,952,606    

Indirect Value

   $413,420,042      
Total Shares   41,431,671      
Total Value   $433,372,648      


Seagen Inc $9,493,396 Paratek Pharmaceuticals Inc $2,635,786 Icagen Inc $0 MEI Pharma Inc $7,808,658 Aravive Inc $1,276 Syros Pharmaceuticals, Inc. $13,490 Seagen Inc $9,493,396 Paratek Pharmaceuticals Inc $2,635,786 Icagen Inc $0 MEI Pharma Inc $7,808,658 Aravive Inc $1,276 Syros Pharmaceuticals, Inc. $13,490
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    5   
    3    

     Stock price went up :
    4   
    1    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   4.0   
   4.0   
     Percentage Gain/Loss :
   28.4%
 -84.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmos Corp PARS Director 0 2006-10-25 2,845,160    Premium*  
            Seagen Inc SGEN Director 2020-05-15 41,503 2008-09-22 600,559    Premium*  
            Paratek Pharmaceuticals Inc PRTK Former 10% Beneficial ... 2011-07-19 1,181,967 0    Premium*  
            World Heart Corp WHRT 10% Owner 2012-08-02 0 2010-01-26 0    Premium*  
            Icagen Inc ICGN 2011-07-28 200,500 0    Premium*  
            Synageva BioPharma Corp GEVA Former Director 0 2012-06-27 1,026,832    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 2012-07-24 0 2012-07-24 3,028,439    Premium*  
            MEI Pharma Inc MEIP 10% Owner 2013-02-19 2,502,775 0    Premium*  
            Zs Pharma, Inc. ZSPH Director 2015-12-17 0 2014-06-23 609,455    Premium*  
            aTyr Pharma Inc LIFE Former 10% Owner, Dire... 2015-05-12 0 2015-05-12 1,866,126    Premium*  
            Aravive Inc ARAV Director 2019-12-02 31,815 2019-12-02 576,066    Premium*  
            Syros Pharmaceuticals, Inc. SYRS Director 2023-12-21 2,666 2023-12-21 1,786,427    Premium*  
            Principia Biopharma Inc PRNB Director 2018-09-18 0 2018-09-18 383,480    Premium*  
            Chinook Therapeutics Inc KDNY Director 2023-08-11 0 2023-08-11 0    Premium*  
            Lenz Therapeutics LENZ 10% Owner 2021-06-29 0 2022-04-12 8,497,067    Premium*  
            Scholar Rock Holding Corp SRRK Director, 10% Owner 0 2023-10-16 6,788,609    Premium*  
            Cargo Therapeutics, Inc. CRGX 10% Owner 0 2023-11-14 4,121,689    Premium*  
            Mineralys Therapeutics, Inc. MLYS 2024-02-12 0 2024-02-12 5,074,916    Premium*  
            Vtv Therapeutics Inc. VTVT 2024-02-27 0 2024-02-27 265,620    Premium*  
* Premium Members only  

Records found :    123         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Director   –       •      –    2020-05-15 4 A $0.00 $0 D/D 1,335 41,503 0 -
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2020-06-23 4 AS $11.11 $565,930 I/I (50,953) 1,542,317 0 %
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2020-06-24 4 AS $11.07 $539,788 I/I (48,775) 1,493,542 0 %
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2020-06-25 4 AS $11.15 $612,850 I/I (54,972) 1,438,570 0 %
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2020-07-01 4 AS $11.01 $50,966 I/I (4,627) 1,433,943 0 %
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2020-08-17 4 AS $13.00 $9,672 I/I (744) 1,433,199 0 %
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2020-08-18 4 AS $13.10 $2,076,724 I/I (158,583) 1,274,616 0 %
KDNY Chinook Therapeutics Inc Director   –       •      –    2020-10-05 4 A $0.00 $0 I/I 3,168,388 3,168,388 0 -
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2020-12-08 4 A $0.00 $0 I/I 625,000 1,899,616 0 -
LENZ Lenz Therapeutics 10% Owner   –       –       •   2021-06-29 4 A $0.00 $0 I/I 6,931,623 22,753 0 -
LENZ Lenz Therapeutics 10% Owner   –       –       •   2021-06-29 4 B $17.00 $8,500,000 I/I 500,000 37,753 1.5 %
KDNY Chinook Therapeutics Inc Director   –       •      –    2021-08-18 4 B $11.98 $2,497,830 I/I 208,500 3,376,888 2.1 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2021-10-06 4 B $13.83 $850,199 I/I 61,475 7,455,345 1.5 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2021-10-07 4 B $14.94 $134,774 I/I 9,021 7,464,366 1.5 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2021-10-08 4 B $13.12 $984,000 I/I 75,000 7,539,366 1.5 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2021-10-13 4 B $13.22 $600,188 I/I 45,400 7,584,766 1.5 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2021-10-14 4 B $12.50 $38,750 I/I 3,100 7,587,866 1.5 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2021-10-15 4 B $12.49 $28,727 I/I 2,300 7,590,166 1.5 %
KDNY Chinook Therapeutics Inc Director   –       •      –    2021-11-15 4 B $14.00 $17,010,000 I/I 1,215,000 4,591,888 2.1 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2021-12-15 4 B $10.19 $227,533 I/I 22,329 7,814,180 1.5 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2022-01-19 4 B $9.24 $504,181 I/I 54,565 7,868,745 1.5 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2022-01-20 4 B $8.92 $384,497 I/I 43,105 7,911,850 1.5 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2022-01-21 4 B $8.99 $899,000 I/I 100,000 8,011,850 1.5 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2022-01-24 4 B $8.70 $200,100 I/I 23,000 8,034,850 1.5 %
LENZ Lenz Therapeutics 10% Owner   –       –       •   2022-04-11 4 B $4.07 $303,068 I/I 74,464 8,109,314 1.5 %
  123  Records found
  1   2   3   4  5      
  Page 4 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us